{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Although Abstract"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "does not explicitly mention LINC01252 by name, it describes a study in which three long non‐coding RNAs were evaluated for their prognostic impact in acute myeloid leukemia. In this work, the authors developed a risk score based on the expression of three lncRNAs—long intergenic non‐protein coding RNA 926, a member of the family with sequence similarity 30, and LRRC75A‑AS1. Of these, LRRC75A‑AS1 appears to have a regulatory function, as co‑expression analyses revealed that it is highly associated with the target genes of important transcription factors such as tumor protein 53 (TP53) and ETS variant 6. These findings indicate that the lncRNAs studied, and LRRC75A‑AS1 in particular, may serve as molecular biomarkers by participating in cis/trans regulatory as well as competing endogenous RNA networks, thereby contributing to AML pathogenesis and prognosis.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Fangce Wang, Xiaoxue Tian, Jie Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.9139"}], "href": "https://doi.org/10.3892/mmr.2018.9139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29901168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29901168"}]}]}]}